Lorena Garcia Hevia | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Lorena Garcia Hevia | Drug Delivery Systems | Best Researcher Award

Universidade de Vigo | Spain

Dr. Lorena García Hevia is a distinguished researcher recognized for her pioneering work at the intersection of nanomedicine, microbiology, and biotechnology. As a member of the Hybrid Nanomaterials Research Group at the Galicia Sur Health Research Institute (IIS Galicia Sur), she has dedicated her career to advancing innovative nanotechnological solutions that address critical biomedical challenges. Her research focuses primarily on the design and application of nanoscale systems to improve therapeutic delivery, particularly within the context of infectious disease management and antimicrobial resistance.Affiliated with the CINBIO (Biomedical Research Center) and the Universidade de Vigo in Spain, Dr. García Hevia brings an interdisciplinary approach that bridges biochemical, genetic, and immunological insights with advanced materials science. Her scientific vision emphasizes the development of intelligent nanocarriers that enhance drug stability, optimize bioavailability, and enable targeted therapy. Through this approach, she contributes to transforming conventional treatments into highly efficient, patient-specific solutions.In her recent publication Nanomedicine for Phage Therapy: Encapsulation Strategies for Enhanced Antimicrobial Efficacy, Dr. García Hevia and her colleagues explore the integration of nanotechnology with bacteriophage therapy to overcome limitations in traditional antimicrobial strategies. Her work demonstrates how encapsulation methods—such as polymeric nanoparticles, liposomes, hydrogels, and nanofibers—can significantly improve the stability, delivery, and therapeutic impact of bacteriophages. These innovative formulations facilitate localized and sustained release, providing powerful alternatives against multidrug-resistant infections.Dr. García Hevia’s research is marked by creativity, precision, and translational relevance. Her investigations into responsive nanocarriers and inorganic nanoparticles have opened new avenues for targeted phage delivery, aligning with global efforts to combat antibiotic resistance through sustainable and effective biotechnological interventions. Beyond her scientific achievements, she is deeply engaged in academic mentorship and collaborative research initiatives that strengthen the connection between laboratory innovation and clinical application.Her contributions continue to shape the evolving field of nanomedicine, positioning her as a leading figure in the development of next-generation antimicrobial therapies. Through her commitment to excellence and scientific innovation, Dr. Lorena García Hevia exemplifies the transformative potential of nanotechnology in redefining the future of infection control and precision therapeutics.

Profile: Google Scholar

Featured Publications

García‐Hevia, L., Bañobre‐López, M., & Gallo, J. (2019). Recent progress on manganese‐based nanostructures as responsive MRI contrast agents. Chemistry–A European Journal, 25(2), 431–441.

García-Hevia, L., Valiente, R., Martín-Rodríguez, R., Renero-Lecuna, C., et al. (2016). Nano-ZnO leads to tubulin macrotube assembly and actin bundling, triggering cytoskeletal catastrophe and cell necrosis. Nanoscale, 8(21), 10963–10973.

Rodrigues, R. O., Baldi, G., Doumett, S., García-Hevia, L., Gallo, J., et al. (2018). Multifunctional graphene-based magnetic nanocarriers for combined hyperthermia and dual stimuli-responsive drug delivery. Materials Science and Engineering: C, 93, 206–217.

García‐Hevia, L., Villegas, J. C., Fernández, F., Casafont, Í., González, J., et al. (2016). Multiwalled carbon nanotubes inhibit tumor progression in a mouse model. Advanced Healthcare Materials, 5(9), 1080–1087.

García-Hevia, L., Casafont, I., Oliveira, J., Terán, N., Fanarraga, M. L., & Gallo, J. (2022). Magnetic lipid nanovehicles synergize the controlled thermal release of chemotherapeutics with magnetic ablation while enabling non-invasive monitoring by MRI for melanoma. Bioactive Materials, 8, 153–164.

Hui Li | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hui Li | Drug Delivery Systems | Best Researcher Award

Woosuk University | South Korea

Dr. Hui Li is a distinguished medical scientist and otolaryngologist whose work bridges clinical medicine, translational research, and pharmaceutical innovation. He earned his Ph.D. in Translational Medicine from Seoul National University College of Medicine in Korea, where his research focused on the molecular mechanisms underlying hearing loss and radiation-induced cellular changes. Prior to his doctoral training, he completed both his Master’s and Bachelor’s degrees in Clinical Medicine from Yanbian University of Medicine in China, establishing a strong foundation in clinical diagnostics, therapeutic approaches, and patient-centered medical care.Dr. Li’s professional journey reflects an impressive progression from clinical expertise to cutting-edge biomedical research. He began his career as a medical doctor and otolaryngologist at Yanbian Yongjeong National Hospital, where he honed his clinical acumen in diagnosing and treating ear, nose, and throat disorders. His clinical excellence led him to serve as a resident and research fellow in the Department of Otolaryngology at the Affiliated Hospital of Yanbian University of Medicine, where he began integrating research into his clinical practice. He later worked as a specialist at the Yanbian National Ophthalmology & Otolaryngology Hospital, focusing on complex cases of auditory and vestibular dysfunction. These formative years in medical practice equipped him with invaluable clinical insight that continues to inform his research in translational medicine and pharmacotherapeutics.Dr. Li transitioned into academic research with his appointment as a doctoral researcher at the Department of Translational Medicine (Otolaryngology) at Seoul National University College of Medicine. There, he conducted pivotal studies on novel therapeutic delivery systems, inner ear protection mechanisms, and the molecular pathways involved in hearing impairment. His research excellence earned him postdoctoral appointments at the Cancer Research Institute within the same university, where he explored immune-modulatory effects of radiotherapy and the potential of macrophage polarization in mitigating cancer progression. Currently, he serves as a Postdoctoral Research Fellow at the Laboratory of Biopharmaceutics, Industry-Academia Cooperation Foundation, Woosuk University, Korea, where he investigates advanced drug formulations, biopharmaceutical delivery mechanisms, and the translational potential of controlled-release therapeutics.

Profile: Scopus

Featured Publications

Li, J., Wang, H., Zhang, Y., & Chen, L. (2022). Comprehensive intervention and effect of martial arts routines on children with autism. Journal of Environmental and Public Health, 2022.

Teodora-Eliana Petcov | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Teodora-Eliana Petcov | Drug Delivery Systems | Best Researcher Award

Teodora-Eliana Petcov at National University of Science and Technology POLITEHNICA Bucharest | Romania

Teodora Eliana Petcov is a driven biomedical researcher with a strong foundation in biomaterials, molecular biology, and nanotechnology. Passionate about innovation in drug delivery and regenerative medicine, she has already co-authored scientific publications in reputed journals. Her international internships, multidisciplinary skills, and involvement in EU-funded research projects underscore her commitment to advancing medical technologies. Teodora balances research excellence with volunteer leadership, contributing to both academic and community-driven initiatives. With a sharp analytical mind, hands-on lab experience, and cross-cultural exposure, she exemplifies the next generation of biomedical scientists focused on improving patient care through science and innovation.

Publication Profile 

Scopus

Education

Teodora holds a Bachelor’s degree in Medical Engineering from the Polytechnic University of Bucharest  with a focus on biomaterials and medical devices. She is currently pursuing her Master’s in Biocompatible Substances, Materials, and Systems at the National University of Science and Technology POLITEHNICA Bucharest. Her thesis explored the internalization of nano-sized devices in biological structures. She was a visiting student at “Horia Hulubei” Nuclear Institute and Floreasca Emergency Hospital. Her academic path is complemented by certifications in English  and psycho-pedagogical training, showcasing both technical expertise and educational versatility.

Experience 

Teodora has completed multiple research internships, including roles in molecular biology and materials science labs. She gained practical expertise in 3D bioprinting, SEM techniques, SolidWorks, and conducted advanced testing like DSC and DMA. She has contributed to projects at the National Institute of Physics and Nuclear Engineering, University of Campania in Italy, and worked on PNRR-funded research on bone regeneration and multiple myeloma. Additionally, she has volunteered extensively in cultural and scientific event organization, holding assistant coordinator roles in Zenezia and MED, where she honed human resources, leadership, and scientific communication skills.

Awards  

Teodora has been recognized for her academic excellence and community involvement from high school through higher education. She received top honors for her Bachelor’s thesis, was selected for the prestigious ROSE program, and presented at the “Info-Practic” National Symposium on artificial intelligence. She participated in EU-supported initiatives like ERASMUS+ “Be a Buddy, Not a Bully” and contributed to major national projects, including the ongoing PNRR-funded research on personalized bone regeneration. Her work on cutting-edge nanostructures and her leadership in volunteer networks demonstrate her well-rounded excellence and dedication to scientific and societal progress.

Research Focus 

Teodora focuses on biomedical applications of nanotechnology, with a keen interest in targeted drug delivery, biopolymeric material synthesis, and regenerative medicine. Her Master’s research and publications revolve around understanding how nanostructures interact with cellular systems to improve treatment precision in diseases like multiple myeloma. She also explores the use of 3D printed biomaterials and advanced materials characterization techniques (SEM, DSC, DMA). Her interdisciplinary research combines materials science, molecular biology, and bioengineering to design patient-specific, low-toxicity solutions, positioning her at the frontier of precision and personalized medicine.

Publication Top Notes

Title: Nanostructures: An Efficient Drug Delivery Platform for Therapy of Multiple Myeloma
Year: 2025

Conclusion

Teodora Eliana Petcov is a highly promising emerging researcher whose interdisciplinary approach, early scientific contributions, and strong practical expertise align closely with the vision of the Best Researcher Award. Her dedication to innovation in biomaterials, nanotechnology, and regenerative medicine showcases both depth and futuristic relevance.

Prof Dr.Dinesh Mishra, Drug Delivery Systems,Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr.Dinesh Mishra, Drug Delivery Systems ,Best Researcher Award

Prof Dr.Dinesh Mishra, atDepartment of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur,India

Author Profile

 

Educational Background

Dr. Dinesh Kumar Mishra holds a Ph.D. in Pharmaceutics from Dr. H. S. Gour University, Sagar, where he studied under the supervision of Prof. N. K. Jain. He completed his M. Pharm. in Pharmaceutics from the same institution, achieving a merit-holder distinction. Dr. Mishra’s academic journey began with a B. Pharm. degree from Dr. H. S. Gour University, followed by secondary education credentials from the M.P. Board.

Professional Experience

Dr. Mishra has an extensive teaching and administrative career spanning over two decades. He is currently a Professor at Guru Ghasidas Vishwavidyalaya, a position he has held since July 2023. Prior to this, he served as Principal and Professor at Indore Institute of Pharmacy and held various academic roles at NMIMS, IPS Academy, SLT Institute of Pharmaceutical Sciences, Mahakal Institute of Pharmaceutical Studies, Shri Ram Institute of Technology, and AND College of Pharmacy.

Teaching and Administrative Roles

  • UG Teaching Experience: 21 years
  • PG Teaching Experience: 19 years
  • Principal at Indore Institute of Pharmacy: 4 years
  • HOD, M. Pharm (Pharmaceutics): 8 years
  • Exam Center Superintendent, IPS Academy College of Pharmacy: 2 years
  • Academic In-charge, IPS Academy College of Pharmacy: 2 years

Research Credentials

Dr. Mishra’s research credentials are noteworthy, with a cumulative impact factor of 245, 4700 citations, an h-index of 38, and an i-10 index of 58. He has guided numerous students at both undergraduate and postgraduate levels, as well as Ph.D. candidates.

Ph.D. Research Supervision

  1. Dr. Shriprakash Mishra – Development of mucoadhesive microsphere for the treatment of peptic ulcer (Awarded)
  2. Mr. Pritam R. Siraskar – Formulation, characterization, and optimization of gastro retentive floating microspheres using quality by design approach (Awarded)
  3. Mr. Devkant Sharma – Formulation, evaluation, and optimization of nanotechnology-based drug delivery system for psoriasis treatment (Awarded)
  4. Ms. Nayany Sharma – Development of silver nanoparticles-based topical gel containing herbal actives for wound healing
  5. Ms. Neha Kamalpuria – Formulation, optimization, and evaluation of lipid-based nanocarrier gel for topical drug delivery
  6. Ms. Triveni – Design, optimization, and characterization of antifungal drug loaded transferosome based hydrogels for the management of foot dermatophytosis

Honors and Awards

Dr. Mishra has received numerous accolades for his contributions to pharmaceutical sciences, including being listed among the world’s top 2% scientists by Elsevier in 2022 and 2023. He has also received several prestigious awards such as the Prof. M. L. Schroff Pharma Recognition Award, the Outstanding Scientist Award, the Best Scientist Award, and the Eminent Principal Award.

Collaborations and Grants

Dr. Mishra has collaborated with notable institutions such as NIPER Ahmedabad, NIREH ICMR Bhopal, and Central University of Rajasthan. He has successfully secured research grants from various bodies, including MPCST, AICTE, NMIMS University, and UGC-BSR.

Professional Memberships
He is a life member of several esteemed professional bodies including APTI, IPA, ISCA, IPGA, APP, SPER, and ISSRF.

🎓Publication Top Noted:

Paper Title :Full factorial design-based development and characterization of ciclopirox olamine loaded transferosomes: An efficient approach for the management of Athlete’s foot

  • Authors:Triveni, Upendra Nagaich, Dinesh Kumar Mishra, Neha Jain
  • Journal:Journal of Drug Delivery Science and Technology
  • Year: 2024
Paper Title :New emerging technologies for genetic toxicity testing
    • Authors: Kuldeep Vinchurkar, Jitendra Sainy, Masheer Ahmed Khan, Sheetal Mane, Dinesh K. Mishra, Pankaj Dixit
    • Journal:Pharmacokinetics and Toxicokinetic Considerations
    • Year: 2022
Paper Title :Features and Facts of a Gastroretentive Drug Delivery System-A Review
  • Authors:Kuldeep Vinchurkar, Jitendra Sainy, Masheer Ahmed Khan, Sheetal Mane, Dinesh K. Mishra, Pankaj Dixit
  • Journal:Turkish Journal of Pharmaceutical Sciences
  • Year:2022
Paper Title :3D Printing for Drug Delivery and its Pharmaceutical Applications – Recent Findings and Challenges
  • Authors: Kuldeep Vinchurkar, Jitendra Sainy, Masheer Ahmed Khan, Sheetal Mane, Dinesh K. Mishra, Pankaj Dixit
  • Journal: International Journal of Pharmaceutical Sciences and Nanotechnology
  • Year: 2022

Paper Title :Recent update of toxicity aspects of nanoparticulate systems for drug delivery

  • Authors: Patnaik, S., Gorain, B., Padhi, S., Choudhury, H., Gabr, G.A., Md, S., Kumar Mishra, D., Kesharwani, P.
  • Journal:European Journal of Pharmaceutics and Biopharmaceutics
  • Year:2021